BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at two virtual conferences in January.
- Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top on Thursday, January 6 at 11:00am ET
- 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10 at 1:30pm ET
SAN RAFAEL, Calif., Jan. 4, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at two virtual conferences in January. To access the live webcasts, please visit: https://investors.biomarin.com/. An archived version of the presentations will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
###
|
Contacts: |
|
|
Investors |
Media |
|
Traci McCarty |
Debra Charlesworth |
|
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
|
(415) 455-7558 |
(415) 455-7451 |
View original content:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-virtual-investor-conferences-in-january-301452837.html
SOURCE BioMarin Pharmaceutical Inc.
Company Codes: NASDAQ-NMS:BMRN
